0
  • Notifications
  • No notifications yet

  • View All Notifications
ChemDmart
Chemxpert Database
  • About
    • About
    • Leadership
    • Advisory Board
  • Products
    • ChemProtel - Product Intelligence
    • CompFolio - One Company Profile
    • CompGroupe - Group Company Profile
    • ChemScape - Data Landscape
    • ChemDmart - E-Market Place
    • DataIntel - Data Analytics/Trends
    • DataFeed - Data News/Feed
    • CompShow- Company Showcase
  • Sources
  • Subscription
  • User Guide
  • Contact
  • Book Demo Log In
  1. Home
  2. All News
  3. Oncotelic Therapeutics Announces Partnership With Vectara
News Feed
course image
  • 25 Apr 2023
  • Admin
  • News Article

Oncotelic Therapeutics Announces Partnership with Vectara

Oncotelic Therapeutics announced a strategic partnership with Vectara to accelerate the development of novel therapies for the treatment of cancer, infectious disease, and ageing. The combination of Vectara's advanced NLU technology with internal AI discovery and development programmes will revolutionise drug discovery and development. This partnership represents a significant step forward for both companies, and anticipates the outcomes from this venture. A LLM is an artificial intelligence (AI) system that uses deep learning algorithms to generate natural language from a large corpus of text. It is trained on a large text dataset and can generate new text similar to the original dataset. Large language models are used for a variety of tasks, such as natural language processing, text generation, and machine translation. LLMs such as ChatGPT took the world by storm forever changing how we do things. The solution is expected to speed up pharmaceutical research to gain relevant and significantly robust results by accelerating the acquisition of insights, potentially leading to groundbreaking solutions for drug discovery and formulation. One of the major challenges faced by scientists and researchers is the laborious and expensive process of sifting through massive research papers and publications to find valuable statistics or data points that could aid in the innovation and creation of new or improved immunotherapies. Publicly available artificial intelligence (AI) tools lack the required depth that subject matter experts need, despite their breadth in searching a large volume of data.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!

Categories

image
Product Related Updates
image
Certificates/Accreditation
image
Approval/Launch
image
Clinical Trial Update
image
Licensing/Partnering/Collaboration Deal
image
ODD/BTA/FTA Status
image
Merger/Acquisition
image
Warning/Recalls

Lifescience Intellipedia Pvt. Ltd.

C-89, Sector-65 Noida-U.P. 201301 (India)
Toll-Free: 18004190155
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com

USEFUL LINKS

  • Home
  • Privacy Policy
  • Terms & Conditions
  • Terms Of Use
  • Refund Policy
  • Blogs

OUR PRODUCTS

  • ChemProtel - Product Intelligence
  • CompFolio - One Company Profile
  • CompGroupe - Group Company Profile
  • ChemScape - Data Landscape
  • ChemDmart - E-Market Place
  • DataIntel - Data Analytics/Trends
  • DataFeed - Data News/Feed
  • CompShow- Company Showcase

LOCATION

© Copyright Lifescience Intellipedia Pvt. Ltd.. All Rights Reserved

Fill The Form